NeuroOne Medical Technologies Corporation

NMTC Healthcare Medical Devices

In the quarter to June 2026, revenue grew 16.3%, EPS fell 27.8% and free cash flow grew 26.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

0.96 0.08 −7.69%
Market cap
$9.5M
P/E
0.0×
Fwd P/E
−5.1×
Dividend yield
—
F-score
6/9
Altman Z
−3.72
Beneish M
0.13
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

6 4 3 2
ROE
(91.34%) (146.27%) (223.76%) (124.66%)
ROA
(44.63%) (90.61%) (115.42%) (87.56%)
ROIC
(526.10%) (168.23%) (202.41%) (287.08%)
Return on Tangible Assets
(44.06%) (96.81%) (122.86%) (188.51%)
Average Days of Receivables
38.16 111.47 75.35 42.36
Free Cash Flow per Share
(0.44) (0.75) (0.89) (0.83)
Free Cash Flow
(2.92) (6.26) (7.57) (7.16)
Other line items

Show all line items

Columns are period end dates